Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin an ribosome inactivating protein from the plant Bougainvillea spectabilis. It has undergone pre-clinical trials for the treatment of ovarian cancer and other solid tumors.
This page contains content from the copyrighted Wikipedia article "Citatuzumab bogatox"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.